CGTX – cognition therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Cognition Therapeutics (CGTX) had its "buy" rating reaffirmed by Chardan Capital. They now have a $4.00 price target on the stock.
Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update
Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results [Yahoo! Finance]
Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results
Cognition Therapeutics Presents Evidence of Zervimesine's Impact on Neuropsychiatric Symptoms of Dementia with Lewy Bodies at AD/PD 2026 [Yahoo! Finance]
Form S-8 COGNITION THERAPEUTICS
Form 10-K COGNITION THERAPEUTICS For: Dec 31
Form 8-K COGNITION THERAPEUTICS For: Mar 26
Form 8-K COGNITION THERAPEUTICS For: Mar 02
Form 4 COGNITION THERAPEUTICS For: Feb 15 Filed by: Ricciardi Lisa
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.